Tofacitinib for Inflammatory Eye Disease

NCT03580343 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Uveitis
Scleritis

Interventions

DRUG: tofacitinib

Sponsor

Washington University School of Medicine